Down-regulation of MSMO1 promotes the development and progression of pancreatic cancer
Authors:
Open Access
- 1 August 2022
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 13 (10) , 3013-3021
Abstract
Background: Methylsterol monooxygenase 1 (MSMO1), as a completely unique tumor biomarker, plays a vital role in the malignant progression of various cancer. Until now, the potential function and pathway of MSMO1 in the development of pancreatic cancer (PC) has not been explored yet, to our knowledge.Keywords
This publication has 36 references indexed in Scilit:
- Epithelial–mesenchymal transition in colorectal cancer metastasis: A system reviewPathology - Research and Practice, 2015
- Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cellsDrug Design, Development and Therapy, 2015
- Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisationBritish Journal of Cancer, 2014
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- The role of sterol-C4-methyl oxidase in epidermal biologyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014
- Signal integration by mTORC1 coordinates nutrient input with biosynthetic outputNature Cell Biology, 2013
- Targeting C4-Demethylating Genes in the Cholesterol Pathway Sensitizes Cancer Cells to EGF Receptor Inhibitors via Increased EGF Receptor DegradationCancer Discovery, 2013
- Calcium Channels and Pumps in Cancer: Changes and ConsequencesJournal of Biological Chemistry, 2012
- Profiling of promoter occupancy by PPARα in human hepatoma cells via ChIP-chip analysisNucleic Acids Research, 2010
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005